Correspondence 0001193125-24-234371 from Upstream Bio, Inc. (UPB) (CIK 0002022626) (UPB)
Upstream Bio, Inc. (UPB) (CIK 0002022626)
Date: Oct. 8, 2024 · CIK: 0002022626 · Accession: 0001193125-24-234371
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282197
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Attention: Chris Edwards, Jimmy McNamara, Kevin Kuhar and Franklin Wyman Re: Upstream Bio, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-282197
Dear Ladies and Gentlemen,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Upstream Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to October 10, 2024 at 4:01 p.m. Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Gabriela Morales-Rivera at (617) 570-1329.
If you have any questions regarding this request, please contact Gabriela Morales-Rivera of Goodwin Procter LLP at (617) 570-1329.
Sincerely,
UPSTREAM BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR October 8, 2024 United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F. Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards, Jimmy McNamara, Kevin Kuhar and Franklin Wyman Re: Upstream Bio, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-282197 Dear Ladies and Gentlemen, Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Upstream Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to October 10, 2024 at 4:01 p.m. Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Gabriela Morales-Rivera at (617) 570-1329. If you have any questions regarding this request, please contact Gabriela Morales-Rivera of Goodwin Procter LLP at (617) 570-1329. Sincerely, UPSTREAM BIO, INC. /s/ E. Rand Sutherland E. Rand Sutherland Chief Executive Officer cc: E. Rand Sutherland, M.D., M.P.H., Upstream Bio, Inc. Michael Paul Gray, M.B.A., Upstream Bio, Inc. Gabriela Morales-Rivera, Esq., Goodwin Procter LLP William D. Collins, Esq., Goodwin Procter LLP Kathryn W. Clerici, Esq., Goodwin Procter LLP